Hill-Zobel R L, Pyeritz R E, Scheffel U, Malpica O, Engin S, Camargo E E, Abbott M, Guilarte T R, Hill J, McIntyre P A, Murphy E A, Tsan M F
N Engl J Med. 1982 Sep 23;307(13):781-6. doi: 10.1056/NEJM198209233071303.
Homocystinuria is an inborn error of metabolism involving a high incidence of thromboembolism. It sometimes improves with large doses of pyridoxine. We investigated the kinetics and distribution of 111Indoxine-labeled platelets in 11 normal volunteers and 12 patients with homocystinuria, none of whom had clinical evidence of acute thrombosis at the time of the study. Six of the patients were resistant to pyridoxine and had homocystinemia. There were no statistical differences in mean platelet-survival times between pyridoxine responders and nonresponders or between normal subjects and pyridoxine responders or nonresponders, regardless of whether a linear, exponential, or multiple-hit model was used to analyze the kinetic data. Plasma homocystine levels had no apparent effect on mean platelet-survival time. There was no abnormal accumulation of platelets in any of the patients, and the distribution of platelets in liver and spleen was similar to that in normal subjects. Our results suggest that the kinetics and distribution of platelets in patients with homocystinuria who have no clinical evidence of thromboembolism are normal. Thus, the data do not provide evidence for disordered platelet function or for an ongoing interaction of platelets with vessel walls in this condition.
同型胱氨酸尿症是一种先天性代谢紊乱疾病,血栓栓塞发生率较高。大剂量维生素B6治疗有时可改善病情。我们研究了11名正常志愿者和12名同型胱氨酸尿症患者体内111铟标记血小板的动力学和分布情况,研究时所有患者均无急性血栓形成的临床证据。其中6名患者对维生素B6耐药且患有高同型胱氨酸血症。无论采用线性、指数或多重打击模型分析动力学数据,维生素B6反应者与无反应者之间、正常受试者与维生素B6反应者或无反应者之间的平均血小板存活时间均无统计学差异。血浆同型胱氨酸水平对平均血小板存活时间无明显影响。所有患者均未出现血小板异常聚集,肝脏和脾脏中的血小板分布与正常受试者相似。我们的结果表明,无血栓栓塞临床证据的同型胱氨酸尿症患者血小板的动力学和分布正常。因此,这些数据并未提供证据表明在这种情况下血小板功能紊乱或血小板与血管壁之间存在持续相互作用。